EE04516B1 - Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod - Google Patents

Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod

Info

Publication number
EE04516B1
EE04516B1 EE9800388A EE9800388A EE04516B1 EE 04516 B1 EE04516 B1 EE 04516B1 EE 9800388 A EE9800388 A EE 9800388A EE 9800388 A EE9800388 A EE 9800388A EE 04516 B1 EE04516 B1 EE 04516B1
Authority
EE
Estonia
Prior art keywords
manufacture
vaccines containing
chlamydia psittaci
containing chlamydia
cat
Prior art date
Application number
EE9800388A
Other languages
English (en)
Estonian (et)
Other versions
EE9800388A (et
Inventor
A. Atherton Rebecca
Schmeer Norbert
A. Hallstrom Jean
K. Lane Jennifer
J. Hennessy Kristina
Original Assignee
Bayer Corporation
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corporation, Bayer Aktiengesellschaft filed Critical Bayer Corporation
Publication of EE9800388A publication Critical patent/EE9800388A/xx
Publication of EE04516B1 publication Critical patent/EE04516B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EE9800388A 1996-05-06 1997-04-21 Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod EE04516B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/643,673 US5972350A (en) 1996-05-06 1996-05-06 Feline vaccines containing Chlamydia psittaci and method for making the same
PCT/US1997/007514 WO1997041889A1 (en) 1996-05-06 1997-04-21 Feline vaccines containing chlamydia psittaci and method for making the same

Publications (2)

Publication Number Publication Date
EE9800388A EE9800388A (et) 1999-06-15
EE04516B1 true EE04516B1 (et) 2005-08-15

Family

ID=24581818

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800388A EE04516B1 (et) 1996-05-06 1997-04-21 Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod

Country Status (16)

Country Link
US (1) US5972350A (cs)
EP (1) EP0904106A1 (cs)
JP (1) JP2000510121A (cs)
AU (1) AU717628B2 (cs)
BG (1) BG63564B1 (cs)
BR (1) BR9708975A (cs)
CA (1) CA2203234A1 (cs)
CZ (1) CZ297848B6 (cs)
EE (1) EE04516B1 (cs)
IL (1) IL126628A (cs)
NO (1) NO320871B1 (cs)
NZ (1) NZ332620A (cs)
PL (1) PL329734A1 (cs)
SK (1) SK149198A3 (cs)
TR (1) TR199802259T2 (cs)
WO (1) WO1997041889A1 (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010048927A1 (en) * 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7105171B2 (en) * 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
US7306807B2 (en) 2004-09-13 2007-12-11 Wyeth Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease
CN100423775C (zh) * 2005-04-15 2008-10-08 中国农业科学院兰州兽医研究所 牛衣原体病灭活疫苗及其制备与检验方法
US20080299149A1 (en) * 2007-05-30 2008-12-04 Wyeth Raccoon Poxvirus Expressing Genes of Feline Antigens
FR3039406B1 (fr) 2015-07-28 2020-09-18 Centre Nat Rech Scient Composition vaccinale contre les infections a chlamydiaceae

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
CA2175081A1 (en) * 1993-11-03 1995-05-11 James Evan Sandbulte Vaccine and method for treatment of chlamydial infections

Also Published As

Publication number Publication date
CZ360498A3 (cs) 1999-03-17
JP2000510121A (ja) 2000-08-08
TR199802259T2 (xx) 1999-02-22
PL329734A1 (en) 1999-04-12
CA2203234A1 (en) 1997-11-06
WO1997041889A1 (en) 1997-11-13
AU717628B2 (en) 2000-03-30
EE9800388A (et) 1999-06-15
CZ297848B6 (cs) 2007-04-11
NZ332620A (en) 2000-04-28
NO320871B1 (no) 2006-02-06
IL126628A0 (en) 1999-08-17
AU2996297A (en) 1997-11-26
BR9708975A (pt) 1999-08-03
NO985172L (no) 1999-01-06
BG63564B1 (bg) 2002-05-31
SK149198A3 (en) 2000-02-14
US5972350A (en) 1999-10-26
NO985172D0 (no) 1998-11-05
EP0904106A1 (en) 1999-03-31
MX9703278A (es) 1998-05-31
IL126628A (en) 2002-09-12
BG102890A (en) 1999-09-30

Similar Documents

Publication Publication Date Title
EE03976B1 (et) Erütromütsiinid ja nende valmistamise meetod
EE04540B1 (et) Meetod bioloogiliselt sobivate biodegradeeruvate mikroosakeste valmistamiseks ja mikroosakeste kasutamine
FI973426L (fi) Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
FI97726C (fi) Sulatyöstettävä polyesteriuretaani ja menetelmä sen valmistamiseksi
FI964028L (fi) Uusi farmaseuttinen formulaatio ja menetelmä
FI980043L (fi) Ääntä vaimentava tuote ja menetelmä sen valmistamiseksi
FI980112L (fi) Antiparasiittiset markfortiinit ja paraherkvamidit
FI935377A7 (fi) Kuplia muodostava päällyste ja menetelmä sen valmistamiseksi
BR9607726A (pt) Dispositivo e método para retração de tecido gengival
FI972865L (fi) Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit
FI930076A7 (fi) Systeamiinia sisältävä permanenttauskoostumus ja menetelmä
FI954220L (fi) Yhdistelmä-mersasidiini ja sen valmistusmenetelmä
EE04516B1 (et) Chlamydia psittaciït sisaldavad kassivaktsiinid ja nende valmistamismeetod
FI942298L (fi) Menetelmä ja sovitelma tilaelementtien siirtämiseksi
FI923855L (fi) Katalysaattori ja sen valmistusmenetelmä
FR2746261B1 (fr) Composition insecticide et procede de preparation
FI920035A7 (fi) Tukan kasvua lisäävä aine ja menetelmä sen valmistamiseksi
FI973434A7 (fi) Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi
FI972464L (fi) Diaminoeetterin diklavulanaattisuola ja menetelmä sen valmistamiseksi
DE19749117B4 (de) Pleuelstange und Herstellungsverfahren dafür
DE69524527D1 (de) AIDS-hemmende Arzneizubereitung und Verfahren
KR960007598A (ko) 비스락톤계화합물 및 그 제조방법
DE69614491D1 (de) 5HT1Dalpha und 5HT2A Ligande
FI960655A7 (fi) Aktiivinen kudostekijä sekä menetelmä sen valmistamiseksi

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20080421